Search Within

Paul J Sabbatini

Formats
  1. Journal Article (157)
  2. Meeting Abstract (88)
  3. Book Section (15)
  4. Correspondence (1)
  5. Guidelines (1)
Groups
  1. Department of Medicine (262)
  2. GDMT, Medicine (262)
  3. Gynecologic Medicine Service (262)
  4. Gynecology Disease Management Team (262)
  5. Solid Tumor Oncology Division (262)
  6. Epidemiology and Biostatistics (82)

More Groups

People
  1. Carol Aghajanian (125)
  2. David Spriggs (81)
  3. Martee Hensley (81)
  4. Jason Konner (52)
  5. William Tew (52)
  6. Alexia Iasonos (44)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (7)
  4. 2022 (9)
  5. 2021 (4)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (72)
  2. Gynecologic Oncology (53)
  3. Clinical Cancer Research (17)
  4. International Journal of Gynecological Cancer (15)
  5. Journal of the National Comprehensive Cancer Network (11)
  6. Cancer (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (76)
  2. Elsevier Inc. (68)
  3. American Association for Cancer Research (23)
  4. Lippincott Williams & Wilkins (19)
  5. Harborside Press (11)
  6. Taylor & Francis Group (6)

More Publishers

Results (262)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Engaging community-based cancer physicians: Experience of the Memorial Sloan Kettering Cancer Center Cancer Alliance
    Journal Article

    Lipitz-Snyderman, A.; Kennington, J.; Hogan, B.; Korenstein, D.; Kalman, L.; Nair, S.; Yu, P.; Sabbatini, P.; Pfister, D.
    Journal of the National Comprehensive Cancer Network (2019)

    Fulltext@MSK | Save
  • Ovarian cancer, version 1.2019: Featured updates to the NCCN Guidelines
    Guidelines

    Armstrong, D. K.; Alvarez, R. D.; Bakkum-Gamez, J. N.; Barroilhet, L.; Behbakht, K.; Berchuck, A.; Berek, J. S.; Chen, L. M.; Cristea, M.; DeRosa, M.; more...
    Journal of the National Comprehensive Cancer Network (2019)

    Fulltext@MSK | Save
  • Resource utilization within 30 days of car T cells for hematologic malignancies
    Meeting Abstract

    Shah, G.; Park, J.; Sauter, C.; Duck, E.; Halton, E.; Batlevi, C.; Palomba, M. L.; Younes, A.; Geyer, M.; Smith, E.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  • A phase 1b dose escalation study of ipafricept (OMP—54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer
    Journal Article

    Moore, K. N.; Gunderson, C. C.; Sabbatini, P.; McMeekin, D. S.; Mantia-Smaldone, G.; Burger, R. A.; Morgan, M. A.; Kapoun, A. M.; Brachmann, R. K.; Stagg, R.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
    Journal Article

    Boland, J. L.; Zhou, Q.; Martin, M.; Callahan, M. K.; Konner, J.; O'Cearbhaill, R. E.; Friedman, C. F.; Tew, W.; Makker, V.; Grisham, R. N.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission
    Meeting Abstract

    O'Cearbhaill, R. E.; Gnjatic, S.; Aghajanian, C.; Iasonos, A.; Konner, J. A.; Losada, N.; Sarasohn, D.; Rasalan, T.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase III randomized controlled trial of secondary surgical cytoreduction (SSC) followed by platinum-based combination chemotherapy (PBC), with or without bevacizumab (B) in platinum-sensitive, recurrent ovarian cancer (PSOC): A NRG Oncology/Gynecologic Oncology Group (GOG) study
    Meeting Abstract

    Coleman, R. L.; Enserro, D.; Spirtos, N.; Herzog, T. J.; Sabbatini, P.; Armstrong, D. K.; Kim, B.; Fujiwara, K.; Walker, J. L.; Flynn, P. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • GOG213
    Meeting Abstract

    Coleman, R. L.; Enserro, D.; Herzog, T. J.; Sabbatini, P.; Armstrong, D. K.; Kim, B.; Fujiwara, K.; Walker, J. L.; Spirtos, N.; Flynn, P. J.; more...
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save
  • A phase III randomized controlled trial of secondary cytoreductive surgery (SCS) followed by platinum-based chemotherapy (PC) platinum-sensitive, recurrent ovarian cancer (PSOC) - Surgical parameters
    Meeting Abstract

    Coleman, R. L.; Enserro, D.; Herzog, T. J.; Sabbatini, P.; Armstrong, D. K.; Kim, B.; Fujiwara, K.; Walker, J. L.; Spirtos, N.; Flynn, P. J.; more...
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save
  • Resource utilization early after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J. H.; Sauter, C. S.; Duck, E.; Halton, E.; Palomba, M. L.; Batlevi, C. L.; Younes, A.; Geyer, M. B.; Smith, E. L.; more...
    Blood (2018)

    Fulltext@MSK | Save